Hemenway Trust Co LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Hemenway Trust Co LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$19,558,354
+1.0%
192,012
+0.1%
2.05%
+8.0%
Q2 2023$19,355,256
+12.5%
191,807
+2.6%
1.90%
+4.2%
Q1 2023$17,203,735
+2.6%
186,997
+1.1%
1.82%
-2.3%
Q4 2022$16,775,685
+16.9%
184,917
-2.0%
1.86%
+10.6%
Q3 2022$14,346,000
-10.3%
188,742
-0.2%
1.69%
-7.4%
Q2 2022$15,994,000
-10.5%
189,210
-7.1%
1.82%
+6.1%
Q1 2022$17,866,000
-1.5%
203,606
-1.8%
1.72%
+3.9%
Q4 2021$18,139,000
+0.6%
207,377
-5.9%
1.65%
-9.3%
Q3 2021$18,027,000
-12.5%
220,431
-2.4%
1.82%
-12.3%
Q2 2021$20,603,000
+5.1%
225,815
-1.5%
2.08%
-3.1%
Q1 2021$19,596,000
-6.5%
229,249
+3.3%
2.14%
-10.6%
Q4 2020$20,955,000
+11.2%
221,907
+2.4%
2.40%
-2.1%
Q3 2020$18,842,000
+0.2%
216,672
+0.7%
2.45%
-6.3%
Q2 2020$18,802,000
+8.0%
215,270
+1.9%
2.61%
-11.2%
Q1 2020$17,414,000
-10.9%
211,201
+2.4%
2.94%
+4.8%
Q4 2019$19,534,000
+9.6%
206,294
+0.6%
2.81%
+0.6%
Q3 2019$17,821,000
-4.1%
205,073
+0.8%
2.79%
-2.7%
Q2 2019$18,584,000
-4.3%
203,524
+0.7%
2.87%
-8.4%
Q1 2019$19,428,000
+24.8%
202,082
+11.4%
3.13%
-1.5%
Q4 2018$15,571,000
-6.3%
181,453
-5.9%
3.18%
+13.6%
Q3 2018$16,623,000
+17.0%
192,930
+2.6%
2.80%
+6.8%
Q2 2018$14,203,000
-0.8%
188,019
+6.1%
2.62%
-3.8%
Q1 2018$14,321,000
+0.3%
177,135
+4.1%
2.72%
+0.1%
Q4 2017$14,283,000
+2.5%
170,114
+4.8%
2.72%
-6.4%
Q3 2017$13,932,000
+5.7%
162,288
+2.8%
2.91%
-0.8%
Q2 2017$13,182,000
+17.5%
157,921
+4.5%
2.93%
+13.4%
Q1 2017$11,220,000
+13.8%
151,071
+11.6%
2.58%
+3.9%
Q4 2016$9,857,000
-7.2%
135,321
+0.6%
2.49%
-6.5%
Q3 2016$10,625,000
-2.3%
134,566
+2.1%
2.66%
-6.2%
Q2 2016$10,877,000
+19.2%
131,826
+4.6%
2.84%
+15.1%
Q1 2016$9,127,000
-14.9%
125,996
+1.1%
2.46%
-12.9%
Q4 2015$10,720,000
-3.5%
124,590
+3.1%
2.83%
-7.8%
Q3 2015$11,109,000
-4.2%
120,860
+2.5%
3.07%
+3.1%
Q2 2015$11,592,000
+3.5%
117,875
+3.8%
2.98%
+1.4%
Q1 2015$11,200,000
+9.2%
113,575
+2.6%
2.93%
-4.3%
Q4 2014$10,254,000
+2.0%
110,660
+3.6%
3.06%
-2.5%
Q3 2014$10,053,000
+4.6%
106,800
+0.6%
3.14%
+7.9%
Q2 2014$9,609,000
+10.1%
106,147
+3.4%
2.92%
+6.1%
Q1 2014$8,727,000
+5.6%
102,641
-0.1%
2.75%
+3.7%
Q4 2013$8,262,000
+5.7%
102,786
+0.8%
2.65%
-9.1%
Q3 2013$7,818,000
+12.4%
101,921
+3.6%
2.91%
-1.8%
Q2 2013$6,956,000
-2.3%
98,373
-1.6%
2.97%
-1.6%
Q1 2013$7,122,00099,9783.02%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders